Low-density-lipoprotein cholesterol in patients treated by a lipid clinic versus a primary care clinic [3]

American Journal of Health-System Pharmacy

Volumn 57, Issue 24, 2000, Pages 2285-

  Dunham, D M ^a   Stewart, R D ^a   Laucka, P V ^a  

^a Bay Pines VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HEALTH CARE PERSONNEL; HUMAN; HYPERLIPIDEMIA; LETTER; MAJOR CLINICAL STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034672037     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/57.24.2285     Document Type: Letter

References (6)

1. Prevention of coronary heart disease with pravastatin in men with hypercholestemia
2. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease anda broad range of initial cholesterol levels
3. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
4. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (Adult Treatment Panel II)
5. Inadequate treatment with HMG-CoA reductase inhibitors by health care providers
6. Barriers to following national cholesterol education program guidelines: An appraisal of poor physician compliance